You are using an unsupported version of . Some features may not work correctly. Please install the latest version of .
IIR's 13th annual business of biosimilars and generic drugs
FDA has been busy preparing for the day when the first biosimilar application is filed. In February, FDA published three draft guidance documents on biosimilars. In May, FDA held a public...
No content found.
There seems to have been an error, please try again.